Cereno Scientific expands collaboration with Dr. Michael Holinstat as Director of Translational Research
Cereno Scientific today announced that Dr. Michael Holinstat, Ph.D., FAHA, takes on the role as Director of Translational Research at Cereno. The role marks a further focus on the importance of Cereno’s early-stage development, for which Dr. Holinstat leads the two current preclinical programs at the University of Michigan. The expansion of the Cereno team adds expertise and secures knowledge important to the company’s portfolio development.“We are happy to have Dr. Michael Holinstat join Cereno to spear head our preclinical stage assets. He has extensive experience in early-stage drug